Price: 0.33

Today's Change: 0.0

Today's Percent Change: 0%

Today's Volume: 0

Average Daily Volume: 279022

52 week low: 0.24

52 week high: 1.4

Market cap: 0.0

EBITDA: 0.0

EBITDA / market_cap: 0%

Earnings per Share (EPS): -0.12

EPS / price: -36.36%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 0.0

Price to Book Ratio: 0.0

Price to Earnings (P/E) Ratio: 0.0

Price to Earnings Growth (PEG) Ratio: 0.0

Price to Sales (P/S) Ratio: 0.0

Short Ratio: 0.0

Exchange: "NCM"

Short term: SIDEWAYS (Previous: UP)

Mid term: DOWN (Previous: DOWN)

Long term: DOWN (Previous: DOWN)

Support: 0.33

Resistance: 0.33

Pivot point: 0.33

SMA 10: 0.33

SMA 50: 0.37

SMA 100: 0.46

RSI 10: 34.98

RSI 50: 38.66

RSI 100: 38.64

EMA 10: 0.33

EMA 50: 0.38

EMA 100: 0.48

STRONG SELL

Based on 0 buy signals and 12 sell signals

Previous signal: strong sell

0.33

POSITIVE

ONCY
ONCY

@gary_gsr: @Oncolytics $ONCY is firing on all cylinders! This company should be profiled on 60 minutes. It is uplifting scienc… https://t.co/KWMFs5eKa1

@MACDcurlingup: Just putting ones nose to the grind stone! Winners today $VKTX $CLDX $ONCY and $AITB all long. Day scalps $MYSX… https://t.co/hBP7tbUHwy

@thefinreviewer: Adial Pharmaceuticals Inc. $ONCY Contrasting side by side https://t.co/HC6sZ1GAWu

@r_holliday2: $ONCY https://t.co/1XnqGdHTGc

@thefinreviewer: Reviewing Fate Therapeutics Inc. $ONCY's results https://t.co/ZYBXQZwtwT

@r_holliday2: $ONCY Don't miss the train. No investing advice intended. Adlai Nortye Receives NMPA Approval for Pelareorep (AN100… https://t.co/oLU52xzm2L

@RobinDavison2: $ONCY Chinese partner Adlai Nortye receives clearance from CFDA to enroll for P3 trial of pelareorep + paclitaxel i… https://t.co/xzFzKHvpzA

@MACDcurlingup: $ONCY getting ready! https://t.co/BkpCVFcyFz

@moefromcanada: RT @Oncolytics: “The virus gets into cancer cells specifically, engaging and training the patient’s immune system to be its more important…

@michele_fraser: RT @Oncolytics: “The virus gets into cancer cells specifically, engaging and training the patient’s immune system to be its more important…

@biostockguru: $ONCY Upcoming presentation at #aacr Will get noticed soon https://t.co/N0EjvBum0I

@thefinreviewer: Viking Therapeutics Inc. $ONCY https://t.co/A47xe8TLBc

@Bewitched9: RT @Oncolytics: “The virus gets into cancer cells specifically, engaging and training the patient’s immune system to be its more important…